- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Here are Tuesday's top research calls, including upgrades for Bluebird Bio and Tenet Healthcare, a downgrade for Cognizant and new coverage of Hormel.
U.S. stock futures trade mixed Friday as Wall Street turns its attention to U.S. jobs data and as oil prices reverse a sharp slide overnight.
Technology consultancy Infosys is announcing plans to hire thousands of American workers in an effort to woo the White House after being name-checked as a foreign worker visa abuser.